The first clinical guideline on stroke in childhood was published by the Royal College of Physicians (RCP) in 2004. These guidelines may no longer reflect the best and most up-to-date clinical practice, and as such required urgent updating to ensure utilisation of current evidence.
This 2017 iteration of the clinical guideline delivers an update and scope extension, and provides guidance on the identification, diagnosis, management and rehabilitation of children and young people (aged 29 days to 18 years at time of presentation) with arterial ischaemic stroke (AIS) and haemorrhagic stroke (HS).
Link to guidance here
National Institute of Allergy and Infectious Diseases: Addendum Guidelines for the Prevention of Peanut Allergy in the United States Summary for Clinicians.
In 2015, findings from the landmark Learning Early About Peanut Allergy (LEAP) study—the first randomized trial to study early allergen introduction as a preventive strategy—showed that early introduction of peanut-containing foods to infants at high risk of developing peanut allergy was safe and led to an 81 percent relative reduction in the subsequent development of peanut allergy. Based on the size of the observed effect and the statistical significance of this result, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), established a coordinating committee and convened an expert panel to develop clinical guidelines to address the prevention of peanut allergy. These guidelines are an Addendum to the 2010 Guidelines for the Diagnosis and Management of Food Allergy in the United States.
These new guidelines have been published by a multi-agency working group convened by The Royal College of Pathologists (RCPath) and The Royal College of Paediatrics and Child Health (RCPCH). They provide a protocol for the handling of sudden infant death, make recommendations to each profession and outline best practice for each part of the investigation process.